RecruitingNCT04567706
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Analysis of the Tumor Microenvironment and Immune Response in Malignant Melanoma
Sponsor
Ohio State University Comprehensive Cancer Center
Enrollment
1,000 participants
Start Date
May 7, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.
Eligibility
Inclusion Criteria4
- Patient with malignant melanoma or personal history of melanoma
- Normal donors
- Informed consent can be obtained
- Patients with any stage of malignant melanoma
Exclusion Criteria1
- Incarcerated individuals will be excluded from this protocol
Interventions
PROCEDUREBiospecimen Collection
Undergo collection of blood and tissue samples
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04567706
Related Trials
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT0711504311 locations
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401152 locations
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
NCT0233266817 locations
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT000018231 location